HempMeds Showcases Retail-Ready Cannabidiol (CBD) Hemp Oil Products Available in All 50 U.S. States and Territories
SAN DIEGO, Nov. 6, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMeds™ – a corporate portfolio company, exclusive master distributor and contracted marketing company – is the premier sponsor of the 3rd annual Marijuana Business Conference. The conference will be held November 12-14 at the Rio All-Suites Hotel & Casino in Las Vegas, Nevada, and feature more than 125 vendors and host an estimated 2,000 attendees. (Note: Visit the conference website for admission guidelines and pricing.)
“From the NFL addressing concussions and consumers ranging from toddlers to seniors, the nation is waking up to taking action and lifting the prohibition on cannabis,” states Andrew Hard, spokesperson for HempMeds™. “This week the nation voted on medical cannabis use and the topic is top of mind with the public. It is perfect timing for HempMeds™ to be the premier sponsor of the 3rd annual National Marijuana Business Conference in Las Vegas.”
According to MMJ Business Daily, “The Nevada Department of Health and Human Services on Monday awarded 55 preliminary licenses for dispensaries and more than 300 for permits [for] other types of medical cannabis businesses.”
Hard continues, “HempMeds™ will showcase a wide variety of retail-ready cannabis products available for purchase from the show floor. We invite the public and newly approved Nevada cannabis business licensees to attend and learn about these unique non-psychoactive cannabis innovations. HempMeds™ provides cannabidiol (CBD) products made from industrial hemp that are already available in all 50 states and more than 40 countries. These natural hemp CBD products allow businesses to get into the ‘green rush’ immediately.”
Marijuana Business Daily’s 3rd annual Marijuana Business Conference & Expo offers attendees:
- 28 presentations
- 70 expert speakers
- Keynote by Ben Cohen of Ben & Jerry’s
- Networking with 2,000 industry professionals
- 125 exhibitors featuring the latest products, innovations, and tools to grow a cannabis business
- Marijuana Business Crash Course
- Women’s Business Networking Breakfast
- Investor Pitch Slam featuring live investor presentations
George Jage, President & Publisher of Marijuana Business Daily states, “This is a historic event for the cannabis industry as the largest attended business-to-business marijuana event in North America. The acceleration of the market is staggering with exponential growth potential. As our highest-level event sponsor, HempMeds is a major stand out from our list of 140 exhibiting companies capitalizing on the market’s potential.”
For more information on HempMeds™ and their all-natural CBD hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds™ through the Company’s social media websites on Facebook and Twitter.
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Investor Relations contact:
Medical Marijuana, Inc.
Public Relations contact: